Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Dewit

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Journal of Crohn'S & Colitis|May 14, 2013
Profile of pediatric Crohn's disease in BelgiumE De Greef, J M Mahachie John, I Hoffman, et al.
Acta Gastro-Enterologica Belgica|October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab ExposureA Cremer, A Mansour, T Lobaton, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Journal of Crohn'S & Colitis|May 14, 2013
Profile of pediatric Crohn's disease in BelgiumE De Greef, J M Mahachie John, I Hoffman, et al.
Acta Gastro-Enterologica Belgica|October 13, 2025
Real-world Effectiveness and Safety of Tofacitinib in Multi-Refractory Ulcerative Colitis: insights from a Belgian Cohort with prior Anti-TNF and Vedolizumab ExposureA Cremer, A Mansour, T Lobaton, et al.
Gut|January 6, 2017
Long-term outcome of patients with steroid-refractory acute severe UC treated with ciclosporin or infliximabD Laharie, A Bourreille, J Branche, et al.
Pageof 5